Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis

The Journal of Pediatrics

Volumn 111, Issue 4, 1987, Pages 599-605

  Schaad, Urs B ^a,b   Wedgwood Krucko, Joanna ^a,b   Suter, Susanne ^a,b   Kraemer, Richard ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME;

CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DRUG SPUTUM LEVEL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; THERAPY;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AIRWAY RESISTANCE; AMIKACIN; CEFTAZIDIME; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; HUMAN; OXYGEN CONSUMPTION; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; SUPPORT, NON-U.S. GOV'T; VITAL CAPACITY;

EID: 0023202934     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(87)80130-0     Document Type: Article

References (28)

1. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis
2. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis
3. Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal
4. Antimicrobial chemotherapy in cystic fibrosis patients
5. The art and science of the use of antibiotics in cystic fibrosis
6. Antibiotic use in cystic fibrosis
7. Antibiotic therapy in cystic fibrosis: evaluation of clinical trials
8. Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis
9. Inhaled antibiotics in cystic fibrosis Is there a therapeutic effect?
10. Assay of ceftazidime in biological fluids using high-pressure liquid chromatography
11. Comparison of enzyme immunoassay, radioimmunoassay, and microbiologic assay for amikacin in plasma
12. Relationship between clinical conditions, radiographic findings and pulmonary functions in patients with cystic fibrosis
13. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis: a prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin
14. The systematic evaluation of the chest radiograph in cystic fibrosis
15. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa
16. Reversibility of lung function abnormalities in children with perennial asthma
17. Determination of capillary oxygen tension in infants and children
18. Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis
19. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis
20. Cephalosporin therapeutics in cystic fibrosis
21. Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis
22. Acute pulmonary exacerbations in cystic fibrosis: a double-blind trial of tobramycin and placebo therapy
23. A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis
24. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection
25. Pulmonary deposition of aerosols in children with cystic fibrosis
26. Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis